Diabetic Neuropathy Peripheral Clinical Trial
Official title:
Effects of Interactive Video Game-Based Exercise on Balance in Diabetic Patients With Peripheral Neuropathy
Verified date | September 2018 |
Source | Taipei Medical University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluated the effects of interactive video game-based exercise (IVGB) on balance in diabetic patients with peripheral neuropathy. Twenty-four patients were randomly assigned to two groups (12 participants per group). Group A received IVGB training for the first 6 weeks, with no exercise in the subsequent 6 weeks. Group B had no exercise for the first 6 weeks and then underwent IVGB training in the subsequent 6 weeks. Both subjective and objective measures were used to determine whether IVGB exercise improves balance function.
Status | Completed |
Enrollment | 24 |
Est. completion date | January 2018 |
Est. primary completion date | January 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - 40-80 years of age - medical diagnoses of diabetes under regular medication control and diabetic peripheral neuropathy confirmed using an electrodiagnostic test - independent community ambulatory individuals - intact cognition (Mini-Mental State Examination score of >24). Exclusion Criteria: - other neurological diseases such as dementia, Parkinson's disease, spinal cord injury, or stroke; - severe visual impairment, musculoskeletal disorders, unhealed plantar ulceration, lower limb amputation, poor cardiopulmonary function, or other diseases affecting walking ability or any other disease due to which individuals were unable to walk without assistance - any other condition associated with a high risk of falling. - Inability to follow simple instructions |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of Berg Balance Scale (BBS) score | It consists of 14 functional tasks of varying difficulty, including sitting, standing, changing posture, transfers, reaching forward, retrieving objects, turning, tandem stance, and one-leg stance. It is a valid tool used in both clinical practice and research to evaluate the efficacy of intervention and provide a quantitative description of balance function. The ability to perform each a task is scored on a scale of 0-4, ranging from inability to independently perform the task to successfully completing it, respectively. The maximum possible score for the 14 functional tasks is 56. | 15 minutes/session; measured at weeks 0, 6, and 12 of the experiment | |
Secondary | Change of Time Up and Go (TUG) test time | Participants stand up from a 46-cm-high armchair with back support, walk straight for 3 m, turn around, walk back to the chair, and sit down as quickly and safely as possible. The timing starts when the investigator says "go" and stops when the participant sits back down on the chair. In our study, each participant had three chances to complete the TUG test in each session, and the best result was recorded for each participant. | 5 minutes/session; measured at weeks 0, 6, and 12 of the experiment | |
Secondary | Change of Modified Falls Efficacy Scale (MFES) scores | MFES is a 14-item questionnaire related to daily indoor and outdoor physical activities. It is a 10-point visual analog scale of confidence level in completing a particular activity (item) without falling, rated from 0 to 10, where 0 denotes not confident or sure at all, and 10 denotes completely confident or sure. The total score for the 14 items ranges from 0 to 140. | 10 minutes/session; measured at weeks 0, 6, and 12 of the experiment | |
Secondary | Change of Unipedal Stance Test (UST) time | Participants raised one leg to the ankle level or higher without touching the other leg or using any assistance and then stood on that leg for as long as possible barefoot and with eyes open. The observer measured the length of time for which participants maintained balance; that is, until they were no longer able to keep the leg raised at or above the ankle level or when both legs touched the ground. The observer stopped counting at 45 seconds, recording this as the time for any participant who maintained balance for a longer time. Each participant performed the test three times for both right and left legs, with the best result for each leg recorded. | 5 minutes/session; measured at weeks 0, 6, and 12 of the experiment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05558878 -
Effect of Ambroxol in Diabetic Peripheral Neuropathy
|
N/A | |
Completed |
NCT03440203 -
Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes
|
||
Completed |
NCT03455543 -
Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy
|
N/A | |
Recruiting |
NCT03725917 -
Patients With Diabetic Neuropathy Who Receive Physiotherapy Treatment Will Have a Decrease in Diabetic Foot Ulcers
|
N/A | |
Enrolling by invitation |
NCT03907189 -
Ambulation as a Factor on Oscillating Thermometry
|
||
Completed |
NCT03888872 -
Effect of High Tone Power Therapy on Neurophysiological Measures and Function Outcome in Patients With Diabetic Neuropathy
|
N/A | |
Withdrawn |
NCT03354806 -
Peripheral Analgesia in Painful Diabetic Neuropathy
|
N/A | |
Enrolling by invitation |
NCT05921097 -
Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
|
||
Active, not recruiting |
NCT06463015 -
Posterior Tibial Nerve PRF for Diabetic Neuropathic Pain
|
N/A | |
Completed |
NCT05299918 -
Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan
|
||
Not yet recruiting |
NCT06201611 -
Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.
|
Phase 2/Phase 3 | |
Suspended |
NCT03685253 -
Nicotinamide Riboside for Diabetic Neuropathy
|
Phase 1/Phase 2 | |
Completed |
NCT05977465 -
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
|
Phase 1/Phase 2 | |
Completed |
NCT03847779 -
Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy
|
N/A | |
Recruiting |
NCT05642143 -
Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
|
||
Terminated |
NCT04253860 -
Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy
|
Phase 3 | |
Completed |
NCT03988413 -
Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People
|
Phase 1 | |
Not yet recruiting |
NCT05461274 -
Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients
|
||
Recruiting |
NCT04841720 -
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets
|
Phase 1 |